Kraig Biocraft Laboratories, Inc.

OTCPK:KBLB Stock Report

Market Cap: US$92.4m

Kraig Biocraft Laboratories Past Earnings Performance

Past criteria checks 0/6

Kraig Biocraft Laboratories's earnings have been declining at an average annual rate of -8.4%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 101.6% per year.

Key information

-8.4%

Earnings growth rate

-5.1%

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate-101.6%
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Kraig Biocraft Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:KBLB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-320
30 Sep 230-320
30 Jun 230-320
31 Mar 230-320
31 Dec 220-420
30 Sep 220-420
30 Jun 220-620
31 Mar 220-830
31 Dec 210-830
30 Sep 210-830
30 Jun 210-520
31 Mar 210-320
31 Dec 200-540
30 Sep 200-550
30 Jun 200-650
31 Mar 200-550
31 Dec 190-320
30 Sep 190-320
30 Jun 190-210
31 Mar 190-110
31 Dec 180-110
30 Sep 180-110
30 Jun 180-110
31 Mar 180-220
31 Dec 170-220
30 Sep 170-330
30 Jun 170-430
31 Mar 170-330
31 Dec 160-330
30 Sep 160-320
30 Jun 160-210
31 Mar 160-220
31 Dec 150-220
30 Sep 150-220
30 Jun 150-220
31 Mar 150-210
31 Dec 140-210
30 Sep 140-720
30 Jun 140-820
31 Mar 140-820
31 Dec 130-720
30 Sep 130-221

Quality Earnings: KBLB is currently unprofitable.

Growing Profit Margin: KBLB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KBLB is unprofitable, and losses have increased over the past 5 years at a rate of 8.4% per year.

Accelerating Growth: Unable to compare KBLB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KBLB is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-11.9%).


Return on Equity

High ROE: KBLB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.